196 related articles for article (PubMed ID: 23748383)
1. Methamphetamine-induced increases in putamen gray matter associate with inhibitory control.
Groman SM; Morales AM; Lee B; London ED; Jentsch JD
Psychopharmacology (Berl); 2013 Oct; 229(3):527-38. PubMed ID: 23748383
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.
Groman SM; Lee B; Seu E; James AS; Feiler K; Mandelkern MA; London ED; Jentsch JD
J Neurosci; 2012 Apr; 32(17):5843-52. PubMed ID: 22539846
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.
Okita K; Morales AM; Dean AC; Johnson MC; Lu V; Farahi J; Mandelkern MA; London ED
Mol Psychiatry; 2018 May; 23(5):1320-1327. PubMed ID: 28894300
[TBL] [Abstract][Full Text] [Related]
4. Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.
Morales AM; Kohno M; Robertson CL; Dean AC; Mandelkern MA; London ED
Mol Psychiatry; 2015 Jun; 20(6):764-71. PubMed ID: 25896164
[TBL] [Abstract][Full Text] [Related]
5. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.
Volkow ND; Wang GJ; Smith L; Fowler JS; Telang F; Logan J; Tomasi D
Neuroimage; 2015 Nov; 121():20-8. PubMed ID: 26208874
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.
Lee B; London ED; Poldrack RA; Farahi J; Nacca A; Monterosso JR; Mumford JA; Bokarius AV; Dahlbom M; Mukherjee J; Bilder RM; Brody AL; Mandelkern MA
J Neurosci; 2009 Nov; 29(47):14734-40. PubMed ID: 19940168
[TBL] [Abstract][Full Text] [Related]
7. Effects of HIV-1 TAT protein and methamphetamine exposure on visual discrimination and executive function in mice.
Kesby JP; Fields JA; Chang A; Coban H; Achim CL; Semenova S;
Behav Brain Res; 2018 Sep; 349():73-79. PubMed ID: 29709610
[TBL] [Abstract][Full Text] [Related]
8. Comparison of single-dose and extended methamphetamine administration on reversal learning in rats.
Kosheleff AR; Rodriguez D; O'Dell SJ; Marshall JF; Izquierdo A
Psychopharmacology (Berl); 2012 Dec; 224(3):459-67. PubMed ID: 22760483
[TBL] [Abstract][Full Text] [Related]
9. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.
Moeller SJ; Okita K; Robertson CL; Ballard ME; Konova AB; Goldstein RZ; Mandelkern MA; London ED
Neuropsychopharmacology; 2018 Mar; 43(4):751-760. PubMed ID: 28664927
[TBL] [Abstract][Full Text] [Related]
10. Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users.
Okita K; Ghahremani DG; Payer DE; Robertson CL; Dean AC; Mandelkern MA; London ED
Drug Alcohol Depend; 2016 Apr; 161():163-70. PubMed ID: 26880595
[TBL] [Abstract][Full Text] [Related]
11. Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies.
Proebstl L; Kamp F; Manz K; Krause D; Adorjan K; Pogarell O; Koller G; Soyka M; Falkai P; Kambeitz J
Eur Psychiatry; 2019 Jun; 59():15-24. PubMed ID: 30981746
[TBL] [Abstract][Full Text] [Related]
12. Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals.
Okita K; Ghahremani DG; Payer DE; Robertson CL; Mandelkern MA; London ED
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26657175
[TBL] [Abstract][Full Text] [Related]
13. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects.
Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y
Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446
[TBL] [Abstract][Full Text] [Related]
14. Different forms of self-control share a neurocognitive substrate.
Tabibnia G; Monterosso JR; Baicy K; Aron AR; Poldrack RA; Chakrapani S; Lee B; London ED
J Neurosci; 2011 Mar; 31(13):4805-10. PubMed ID: 21451018
[TBL] [Abstract][Full Text] [Related]
15. Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine.
Morales AM; Lee B; Hellemann G; O'Neill J; London ED
Drug Alcohol Depend; 2012 Oct; 125(3):230-8. PubMed ID: 22445480
[TBL] [Abstract][Full Text] [Related]
16. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.
Sung YH; Cho SC; Hwang J; Kim SJ; Kim H; Bae S; Kim N; Chang KH; Daniels M; Renshaw PF; Lyoo IK
Drug Alcohol Depend; 2007 Apr; 88(1):28-35. PubMed ID: 17084995
[TBL] [Abstract][Full Text] [Related]
17. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.
Kohno M; Okita K; Morales AM; Robertson CL; Dean AC; Ghahremani DG; Sabb FW; Rawson RA; Mandelkern MA; Bilder RM; London ED
Mol Psychiatry; 2016 Nov; 21(11):1554-1560. PubMed ID: 26830141
[TBL] [Abstract][Full Text] [Related]
18. Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning.
Groman SM; Lee B; London ED; Mandelkern MA; James AS; Feiler K; Rivera R; Dahlbom M; Sossi V; Vandervoort E; Jentsch JD
J Neurosci; 2011 May; 31(20):7291-9. PubMed ID: 21593313
[TBL] [Abstract][Full Text] [Related]
19. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
[TBL] [Abstract][Full Text] [Related]
20. Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging.
London ED; Kohno M; Morales AM; Ballard ME
Brain Res; 2015 Dec; 1628(Pt A):174-85. PubMed ID: 25451127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
